SageTech is recycling inhalational anaesthetic agents using patented technology to generate significant cost and environmental benefits for healthcare providers.

SageTech has developed, prototyped, and patented systems to capture, extract and purify inhalational anaesthetic emissions, creating a circular economy for a formerly wasteful pharmaceutical product.

The systems enable cost and emissions savings, flexible theatre design and increased access to clinically superior anaesthetics. Robotics and automation have been integrated to optimise the logistics and scalability of the solution.


Investing in start-ups and early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution.
It should be done only as part of a diversified portfolio. Any investments are targeted exclusively at investors who understand the risks of investing in early-stage businesses and can make their own investment decisions. Any pitches for investment are not offers to the public.

Investments made in investee companies via funds managed by Sapphire Capital Partners LLP are not covered by the Financial Services Compensation Scheme (FSCS). For more details, please contact us or refer to their website: